Rucaparib or Physician's Choice in Metastatic Prostate Cancer
Por um escritor misterioso
Descrição
ESMO 2018: Preliminary Results From TRITON2: A Phase II Study of Rucaparib in Patients with mCRPC Associated with Homologous Recombination Repair Gene Alterations
Rucaparib Efficacious in Metastatic Castration-Resistant Prostate Cancer - Southern Iowa Mental Health Center
Advanced Prostate Cancer: AUA/SUO Guideline - American Urological Association
Rucaparib Bests Physician's Choice in Metastatic Castration-Resistant Prostate Cancer - Cancer Therapy Advisor
Prostate cancer
Prostate cancer: The hunt for a silver bullet - Medical Independent
Rucaparib extends PFS in advanced prostate cancer
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Understanding the Current Therapeutic Landscape for Advanced Prostate Cancer
de
por adulto (o preço varia de acordo com o tamanho do grupo)
